Introduction: Remogliflozin is a sodium–glucose cotransporter-2 inhibitor used for type 2 diabetes mellitus (T2DM), but its overall efficacy and safety remain fragmented. This updated systematic review and meta-analysis evaluated the efficacy and safety of remogliflozin using evidence exclusively from randomized contro...
N. Kostadinov, T. Totomirova, Z. Kirovakov et al.· Endocrines· 0 citations
Background: Maternal undernutrition is associated with impaired fetal growth and adverse pregnancy outcomes, but the effects of food-based nutritional interventions during pregnancy remain uncertain. This systematic review and meta-analysis evaluated their effects on maternal and neonatal outcomes using evidence exclus...
Zlatko Kirovakov, Andriana Jovanoska-Kirovakova, Pavel Dobrev et al.· Journal of Clinical Medicine· 0 citations
Current evidence does not demonstrate a clear benefit of routine early surgery over conservative treatment for TICH and shows an uncertain trend toward longer hospital stay, which should be interpreted cautiously given imprecision and potential confounding by indication.
Plamen Penchev, Daniela Milanova-Ilieva, L. Gaydarski et al.· Brain and Spine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.